Related Experiment Video
Updated: May 16, 2026

Activating Autophagy by Aerobic Exercise in Mice
Published on: February 3, 2017
Autophagy activation via BAG3 gene therapy improves phenotype in a mouse model of LGMD1A
Burcak Ozes1, Lingying Tong1, Kyle Moss1
1Center for Gene Therapy, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH 43205, USA.
Abstract:
Myofibrillar myopathies (MFMs) are a group of protein aggregate diseases characterized by abnormal protein aggregations and myofibrillar disintegration. Myotilinopathy, also named MFM3 or limb-girdle muscular dystrophy type 1A (LGMD1A), is caused by myotilin mutations. Myotilin is degraded by the ubiquitin-proteasome system; however, when this pathway is overloaded under pathophysiological conditions, the protein quality control system leans on the autophagy-lysosome pathway (ALP) to mediate degradation of aggregates. BCL2-associated athanogene 3 (BAG3) protein facilitates aggresome formation and initiates ALP. In this study, we assessed our strategy of reducing the aggregate burden in muscle by overexpressing human BAG3 in TgT57I mice, a model for LGMD1A. Overexpression was achieved by systemic delivery of AAVrh74.tMCK.hBAG3, and outcome measures included functional, histological, and molecular studies. The hBAG3-treated cohort demonstrated increased rotarod duration, treadmill running distance, grip strength, and maximum tetanic response compared to the untreated cohort. Myotilin aggregate burden was significantly decreased, and autophagy levels were normalized in the treated group. As an adaptive response, hBAG3 normalized the endogenous Bag1/Bag3 ratio to that of 3-month-old TgT57I mice. This study provides evidence that our strategy of reducing the aggregate burden in muscle by overexpressing BAG3 may be used as a treatment for protein aggregate myopathies.
Insights
Overexpressing BCL2-associated athanogene 3 (BAG3) protein in mice with myotilinopathy reduced protein aggregates and improved muscle function. This suggests BAG3 may be a therapeutic target for protein aggregate myopathies.
Area of Science:
- Muscle biology
- Proteinopathies
- Autophagy
Background:
- Myofibrillar myopathies (MFMs) involve protein aggregates and muscle fiber disintegration.
- Myotilinopathy (MFM3/LGMD1A) stems from myotilin mutations, with impaired protein degradation pathways.
- The autophagy-lysosome pathway (ALP) handles aggregate clearance when the ubiquitin-proteasome system is overloaded.
Purpose of the Study:
- To evaluate the therapeutic potential of overexpressing human BAG3 (hBAG3) in a mouse model of myotilinopathy (TgT57I mice).
- To assess if BAG3 overexpression can reduce muscle aggregate burden and improve muscle function.
Main Methods:
- Systemic delivery of adeno-associated virus carrying hBAG3 (AAVrh74.tMCK.hBAG3) into TgT57I mice.
- Functional assessments included rotarod, treadmill running, grip strength, and maximum tetanic response.
- Histological and molecular analyses examined myotilin aggregate levels and autophagy markers.
Main Results:
- hBAG3-treated mice showed significant improvements in all functional measures compared to controls.
- Myotilin aggregate burden was substantially reduced, and autophagy levels were normalized post-treatment.
- Endogenous Bag1/Bag3 ratio was normalized in hBAG3-treated mice, indicating adaptive response.
Conclusions:
- Overexpression of BAG3 effectively reduces myotilin aggregate burden in a mouse model of myotilinopathy.
- BAG3-based gene therapy demonstrates therapeutic potential for treating protein aggregate myopathies.
- Restoring protein homeostasis via BAG3 modulation offers a promising therapeutic strategy.
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Lysosomal Hydrolases
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...

